Familial risk of breast cancer by dynamic, accumulative, and static definitions of family history

被引:17
作者
Mukama, Trasias [1 ,2 ,3 ]
Kharazmi, Elham [1 ,4 ]
Sundquist, Kristina [4 ,5 ,6 ]
Sundquist, Jan [4 ,5 ,6 ]
Brenner, Hermann [1 ,7 ,8 ]
Fallah, Mandi [1 ,4 ]
机构
[1] German Canc Res Ctr, Natl Ctr Tumor Dis NCT, Div Prevent Oncol, Heidelberg, Germany
[2] Heidelberg Univ, Med Fac Heidelberg, Heidelberg, Germany
[3] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda
[4] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden
[5] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, Dept Family Med & Community Hlth, New York, NY 10029 USA
[6] Shimane Univ, Ctr Community Based Healthcare Res & Educ, Sch Med, Dept Funct Pathol, Matsue, Shimane, Japan
[7] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany
[8] German Canc Res Ctr, German Canc Consortium, Heidelberg, Germany
关键词
breast cancer; familial risk; family history; prospective study; time-dependent;
D O I
10.1002/cncr.32815
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Familial breast cancer risk studies usually overlook the dynamic nature of family history. Methods The authors assessed the effect of incorporating the timing of cancer diagnosis events into the assessment of familial risks of breast cancer in first-degree and second-degree relatives in a nationwide cohort study of 5,099,172 women (follow-up was between 1958-2015). Family history was assessed using 3 approaches: 1) as a static variable (ever having a relative with breast cancer); 2) as accumulative history; and 3) as a dynamic variable (time-dependent variable). Results For women aged <50 years, familial risk was mostly higher when family history was assessed as a dynamic variable compared with using a static or accumulative family history. For example, the cumulative risk of receiving a breast cancer diagnosis until age 50 years for women with a history of breast cancer in 1 first-degree relative was 2.6% (95% CI, 2.5%-2.7%) using the static method, 2.4% (95% CI, 2.3%-2.4%) using the accumulative method, and 3.1% (95% CI, 3.0%-3.2%) using the dynamic method. Relative risk in women aged <50 years with a breast cancer diagnosis in a sister was 1.40-fold (95% CI, 1.31-fold to 1.48-fold) using the static method, 1.66-fold (95% CI, 1.57-fold to 1.76-fold) using the accumulative method, and 2.28-fold (95% CI, 2.07-fold to 2.51-fold) using the dynamic method. Conclusions The results of the current study demonstrated that assessing family history as static, accumulative, or dynamic results in different familial risk estimates. The answer as to which method to use for family history assessment depends on the implications of the study, with the dynamic method appearing to be better suited for risk stratification studies, the accumulative method being the most convenient in practice and the least favored for risk prediction, and the static method being suitable for etiological impact and risk attribution studies.
引用
收藏
页码:2837 / 2848
页数:12
相关论文
共 23 条
  • [1] Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a US Breast Cancer Screening Population
    Ahern, Thomas P.
    Sprague, Brian L.
    Bissell, Michael C. S.
    Miglioretti, Diana L.
    Buist, Diana S. M.
    Braithwaite, Dejana
    Kerlikowske, Karla
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (06) : 938 - 944
  • [2] Epidemiology and prognosis of breast cancer in young women
    Assi, Hussein A.
    Khoury, Katia E.
    Dbouk, Haifa
    Khalil, Lana E.
    Mouhieddine, Tarek H.
    El Saghir, Nagi S.
    [J]. JOURNAL OF THORACIC DISEASE, 2013, 5 : S2 - S8
  • [3] Biology of breast cancer in young women
    Azim, Hatem A., Jr.
    Partridge, Ann H.
    [J]. BREAST CANCER RESEARCH, 2014, 16 (04):
  • [4] Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease
    Beral, V
    Bull, D
    Doll, R
    Peto, R
    Reeves, G
    [J]. LANCET, 2001, 358 (9291) : 1389 - 1399
  • [5] Risk of breast cancer in families of multiple affected women and men
    Bevier, Melanie
    Sundquist, Kristina
    Hemminki, Kari
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 132 (02) : 723 - 728
  • [6] Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort
    Braithwaite, Dejana
    Miglioretti, Diana L.
    Zhu, Weiwei
    Demb, Joshua
    Trentham-Dietz, Amy
    Sprague, Brian
    Tice, Jeffrey A.
    Onega, Tracy
    Henderson, Louise M.
    Buist, Diana S. M.
    Ziv, Elad
    Walter, Louise C.
    Kerlikowske, Karla
    [J]. JAMA INTERNAL MEDICINE, 2018, 178 (04) : 494 - 501
  • [7] Familial risks of breast and prostate cancers: Does the definition of the at risk period matter?
    Brandt, Andreas
    Bermejo, Justo Lorenzo
    Sundquist, Jan
    Hemminki, Kari
    [J]. EUROPEAN JOURNAL OF CANCER, 2010, 46 (04) : 752 - 757
  • [8] Family history and risk of breast cancer: an analysis accounting for family structure
    Brewer, Hannah R.
    Jones, Michael E.
    Schoemaker, Minouk J.
    Ashworth, Alan
    Swerdlow, Anthony J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2017, 165 (01) : 193 - 200
  • [9] Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement
    Calonge, Ned
    Petitti, Diana B.
    DeWitt, Thomas G.
    Dietrich, Allen J.
    Gregory, Kimberly D.
    Grossman, David
    Isham, George
    LeFevre, Michael L.
    Leipzig, Rosanne M.
    Marion, Lucy N.
    Melnyk, Bernadette
    Moyer, Virginia A.
    Ockene, Judith K.
    Sawaya, George F.
    Schwartz, J. Sanford
    Wilt, Timothy
    [J]. ANNALS OF INTERNAL MEDICINE, 2009, 151 (10) : 716 - W236
  • [10] Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications
    Cintolo-Gonzalez, Jessica A.
    Braun, Danielle
    Blackford, Amanda L.
    Mazzola, Emanuele
    Acar, Ahmet
    Plichta, Jennifer K.
    Griffin, Molly
    Hughes, Kevin S.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2017, 164 (02) : 263 - 284